NIH Just Made "Not Discussed" Fundable. NOT-OD-26-114 and the 35,000-Application January 2027 Council.

NIH has posted NOT-OD-26-114, "Continuation of Modifications to Peer Review Practices." It is three paragraphs and four bullets long, it carries no comment period, and it is already operative for applications headed to the January 2027 Advisory Council. It is also the single most consequential change to how NIH applications are judged this year — more consequential, in the near term, than the score-reporting proposal that has absorbed most of the community's attention.

The headline number explains the rest of the notice. NIH says that prior to the receipt deadlines for small business mechanisms, it already has more than 35,000 grant applications under review for the January 2027 Council. The previous record was 33,640 applications reviewed for the May 2026 Council. The small business deadlines had not yet landed when NIH wrote that sentence, which means the final January 2027 figure will be higher still. NIH's own words: it is "necessary to continue modified peer review practices to effectively review an unprecedented number of grant applications."

These modifications were not designed for this. They were improvised after the 2025 lapse in appropriations wiped out a block of study section meetings, and they were applied to the January, May, and October 2026 Councils as a catch-up measure. What NOT-OD-26-114 does is convert a backlog patch into the operating standard for a fourth consecutive round, for a reason that has nothing to do with the original lapse. The emergency is now the volume itself.

The four changes, and what each one actually does

1. Discussion drops to 30-35 percent. In most meetings, the share of applications brought to full committee discussion falls from the usual roughly 50 percent to 30-35 percent. Historically, "streamlined" or triaged applications were the bottom half. Now they are the bottom two-thirds.

2. The middle third becomes "competitive but not discussed" — and remains fundable. This is the change that matters most and is easiest to misread. Applications the committee votes into the middle third are designated "competitive but not discussed." NIH states plainly that these applications "will be considered for funding, along with the discussed applications." Applications in the lowest third are designated "not competitive and not discussed."

3. Summary statements get thinner. The narrative paragraph summarizing committee discussion — the resume of discussion — will not be used. In its place: one sentence describing the degree of consensus in the committee vote, plus bullets listing the main score-driving points.

4. What survives. Summary statements for all applications still contain the written critiques from the three assigned reviewers, as they do today. Summary statements for discussed applications still carry the overall impact score.

Why bullet two breaks a twenty-year habit

For two decades, the operational meaning of "not discussed" at NIH was unambiguous: your application was dead for that round. Triage was terminal. Every institutional decision rule, every mentor's advice, every internal resubmission workflow encoded that assumption. "ND" meant start over or walk away.

NOT-OD-26-114 severs that link for the middle third. A "competitive but not discussed" application was never debated by the panel, has no overall impact score, generated no discussion narrative — and sits in the same funding consideration pool as applications that were discussed for twenty minutes.

Read that against the arithmetic and the reason becomes obvious. If discussion falls to 30-35 percent while application volume sets a record, then the discussed set is far too small to fill NIH's portfolio. In fiscal year 2026 NIH obligated its full extramural budget of roughly $34 billion but funded about 58,000 projects, down from 61,000 in FY2025 and from roughly 63,700 before 2025. Paying out $34 billion against a discussed pool capped near a third of a record application pile does not arithmetically work. The middle third has to be fundable. NIH has simply said so out loud.

The consequence for applicants is that triage is no longer self-interpreting. Last year, the absence of a score told you the answer. This year, the absence of a score is ambiguous between "still in contention" and "finished," and the notice gives you exactly one word of difference between those two states: competitive versus not competitive.

The information squeeze

Stack the four bullets and a pattern emerges. The discussed set shrinks by a third. The discussion narrative is deleted for everyone. The middle third gets no impact score because it was never discussed. What remains as substantive feedback, for the large majority of applications, is the three assigned reviewers' written critiques and a consensus sentence.

That is a real narrowing, and it hits precisely the part of the summary statement that historically carried information the critiques did not. The three written critiques are drafted before the meeting. The resume of discussion captured what happened during it — which concerns the panel amplified, which a reviewer abandoned under challenge, where the committee overrode an assigned reviewer's enthusiasm. Applications that moved substantially between preliminary scores and final vote were exactly the applications whose resume of discussion mattered most, because the critiques alone could not explain the movement. NIH has replaced that with a consensus descriptor and score-driving bullets.

Now layer on the other NIH proposal in flight. NOT-OD-26-088, whose comment period closes October 13, 2026, would stop releasing overall impact scores and percentiles entirely, substituting three bands. We covered that proposal and what it does to resubmission decisions in detail in NIH Wants to Stop Telling You Your Score.

The two documents are not the same thing, and conflating them is the most common error in the current commentary. NOT-OD-26-088 is a proposal out for comment. NOT-OD-26-114 is in force now. But they point the same direction, and NOT-OD-26-114 quietly pre-delivers a chunk of the proposal's effect: for every application in the middle or bottom third of the January 2027 Council — two-thirds of a record pile — there is no overall impact score to withhold, because no score was ever assigned. The blackout is already the lived experience of most applicants, by a different mechanism.

What to do with this before January

Stop treating the absence of a score as a verdict. Read your designation language with care. "Competitive but not discussed" and "not competitive and not discussed" are different outcomes with the same old shorthand. If your institution's internal tracking collapses both into "triaged," fix the field now, before January statements arrive. Mislabeling a live application as dead is a self-inflicted loss.

Make the program officer the primary channel, not the backup. This follows directly from the notice rather than from general advice. If you land in the competitive-but-not-discussed tier, you have no score, no percentile, and no discussion narrative — and you are nonetheless under funding consideration. The only person who can tell you where you stand is the program officer, who can see the vote placement and the Institute's selection thinking. That conversation was once optional. For a middle-third application it is now the entire information channel.

Mine the criterion scores harder. With the resume of discussion gone, the assigned reviewers' criterion and factor scores carry more diagnostic weight per unit of text than they used to. A Significance score two points worse than Approach points to a different revision than the reverse, and that signal is intact.

Write for the pre-meeting read. When two-thirds of applications are never discussed, the three assigned reviewers' independent reads determine the outcome for most submissions. Nothing in a discussion will rescue a specific aim that a single assigned reviewer found confusing, because for most applications there is no discussion. Front-load clarity: unambiguous aims, the rationale visible without inference, feasibility addressed where a skeptic will look for it.

Expect compression, and submit early in the window. NIH is managing a record queue with reduced discussion capacity. Administrative timelines have been slipping all year — the FY2026 cycle spent its full budget only after what reporting described as a slow start, with investigators citing review delays. Build schedule slack into any plan that depends on a January 2027 Council outcome.

Comment by October 13 if you have an institutional position. NOT-OD-26-114 has no comment period. NOT-OD-26-088 closes Monday, October 13, 2026, and it is the live venue for arguing about score transparency. Scientific societies have been filing; an institutional letter still counts.

The part worth saying plainly

There is a reading of NOT-OD-26-114 that is genuinely good news for applicants, and it deserves equal billing with the complaints. Under the old regime, roughly half of all applications were eliminated outright by triage. Under this one, only the bottom third is. The middle third — a cohort that would have been categorically dead last year — is explicitly in the funding pool. For an applicant whose work is solid but not spectacular, the odds structure improved.

What got worse is not the odds. It is the feedback. NIH is funding from a wider pool while telling applicants less about where they sit in it. More applications stay alive; fewer applicants can tell whether theirs is one of them. That trade — broader eligibility purchased with thinner information — is the actual content of the notice, and it is the thing to plan around.

The practical upshot for January 2027: assume you will not learn your position from your paperwork, and build the relationship that can tell you instead.